OFDT's working organisation
The French Monitoring Centre for Drugs and Drug Addiction (OFDT) relies on 2 Scientific Units (DATA and FOCUS), a General Secretariat, a communication and an accountancy department. The tasks of the Centre are carried out by a team of experts and researchers from different disciplines (statistics, demographics, epidemiology, economics, medicine, pharmacology, sociology) as well as administrative and technical staff.
This organisation aims to strengthen our capacity for studies, to develop synergies and partnerships while ensuring promotion and dissemination of our work.
Organisational chart (April 2024)
Directorate
Guillaume Airagnes
Director
Ivana Obradovic
Deputy director
"Data" Unit
Stanislas Spilka
Head of unit
Alex Brissot
Scientific analyst
Vincent Eroukmanoff
Scientific analyst
Eric Janssen
Scientific analyst
Olivier Le Nézet
Scientific analyst
Antoine Philippon
Scientific analyst
Melchior Simioni
Scientific analyst
Sophie Veron
Scientific analyst
"Focus" Unit
Valérie Ulrich
Head of unit
Agnès Cadet-Taïrou
Scientific analyst
Sabrina Cherki
Scientific analyst
Marc-Antoine Douchet
Scientific analyst
Laura Duprat
Scientific analyst
Cindy Feng
Scientific analyst
Clément Gérome
Scientific analyst
Inès Longuet
Scientific analyst
Maitena Milhet
Scientific analyst
Carine Mutatayi
Scientific analyst
Caroline Protais
Scientific analyst
Isaora Rivierez
Scientific analyst
Yasmine Salih
Scientific analyst
Joana Sisternas Tusell
Scientific analyst
General Secretariat
Rébecca Jean-Navarre
Head of unit
Thierry Delprat
Webmaster
Cristina Díaz-Gómez
Scientific analyst
Anne de l'Eprevier
Liaison officer with EMCDDA
Carole Kurzydlowski, legal, financial and adminsitrative officer
Isabelle Michot
Information officer
Frédérique Million
Graphic designer
Marianna Perebenesiuk
Communication officer
Financial resources
Laurence Grandjean
Accountant
Mickael Da Silva
Accounting assistant
Drugs in Europe
2023 EMCDDA European Drug Report
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.
